FAIRVIEW NORTHLAND REG — History
CCN 240141 | 3-year financial timeline | COVID resilience: 73/100
🛡️ Public data only — no PHI permitted on this instance.
$83M
Latest Revenue (FY2022)
+12.5%
Revenue CAGR (3yr)
1.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $66M | $80M | $83M | +4.0% | +12.5% |
| Operating Expenses | $68M | $76M | $83M | +8.2% | +10.3% |
| Operating Margin | -2.7% | 5.1% | 1.2% | -77.1% | +0.0% |
| Net Income | $-2M | $4M | $1M | -76.2% | +0.0% |
| Licensed Beds | 34 | 34 | 34 | +0.0% | +0.0% |
| Total Patient Days | 4,878 | 5,336 | 5,772 | +8.2% | +8.8% |
| Medicare Day % | 29% | 27% | 27% | -0.4% | -3.1% |
| Medicaid Day % | 7% | 7% | 7% | -1.6% | +3.8% |
COVID Impact & Recovery
Resilience Score: 73/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +26.5% ($66M → $83M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+12.5%
This Hospital
+7.6%
State Avg
Latest Margin
1.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $92M | 3.1% |
| FY2024 (proj) | $101M | 5.0% |
| FY2025 (proj) | $110M | 6.9% |